(Q44341642)
Statements
Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule (English)
Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services